Design of genetic construction for creation DNA vaccine against porcine reproductive and respiratory syndrome-Reference-Cited by-同舟云学术

Design of genetic construction for creation DNA vaccine against porcine reproductive and respiratory syndrome

Published:2018-10-30 Issue:4 Volume:63 Page:419-425
ISSN:2524-230X
Container-title:Proceedings of the National Academy of Sciences of Belarus, Biological Series
language:
Short-container-title:Vescì Akademìì navuk Belarusì. Seryâ biâlagičnyh navuk

Author:

Kravchenko L. M.¹,Kudzin K. V.¹,Prakulevich U. A.¹

Affiliation:

1. Belarusian State University

Abstract

The porcine reproductive and respiratory syndrome (PRRS) caused the serious economic damage to swine breeding around the world. It is a viral infective disease against which live attenuated and inactivated vaccines are not always successful. Development of new types of drugs such as DNA vaccines is necessary for improving the protection against the virus. DNA vaccines induce the development of both a cellular and humoral immune response. Such vaccines consist of a plasmid or viral vector with genes of potentially immunogenic proteins. The expression of these genes realized in cells of the vaccinated animal. It leads to the synthesis of antigen proteins triggering the immune response. The purpose of this work is to create a genetic construction that can be used as DNA vaccine against PRRS virus. The construction consists of the commercial vector pVAX1 and open reading frame of two structural proteins of PRRS virus, a lysosomal localization signal sequence of the invariant chain gene and regulatory elements necessary for the expression of cloned genes in mammalian cells.

Publisher

Publishing House Belorusskaya Nauka

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference18 articles.

1. Liu M. A. DNA vaccines: a review. Journal of Internal Medicine, 2003, vol. 253, no. 4, pp. 402–410.

2. Shedlock D. J., Weiner D. B. DNA vaccination: antigen presentation and the induction of immunity. Journal of Leukocyte Biology, 2000, vol. 68, no. 6, pp. 793–806.

3. Coban C., Koyama S., Takeshita F., Akira S., Ishii K. J. Molecular and cellular mechanisms of DNA vaccines. Human Vaccines, 2008, vol. 4, no. 6, pp. 453–457. https://doi.org/10.4161/hv.4.6.6200

4. Labarque G., van Reeth K., Nauwynck H., Drexler C., van Gucht S., Pensaert M. Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy. Vaccine, 2004, vol. 22, no. 31–32, pp. 4183–4190. https://doi.org/10.1016/j.vaccine.2004.05.008

5. Scortti M., Prieto C., Alvarez E., Simarro I., Castro J. M. Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV. Veterinary Record, 2007, vol. 161, no. 24, pp. 809–813.